Paper6540685
Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.
Elliott JA and 8 others. Eur J Cancer Clin Oncol, 1984. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study. Papers, record 6540685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6540685
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Carcinoma | Major topic |
| Lung Neoplasms | Major topic |
| Vinblastine | Major topic |
| Adenocarcinoma | |
| Adult | |
| Aged | |
| Blood Cell Count | |
| Carcinoma, Squamous Cell | |
| Cisplatin | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Random Allocation | |
| Vindesine |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 25929848 | Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases. | Cancer Discov | 2015 | https://conductscience.org/library/papers/25929848 | PubMed |
| 12373594 | Platinum drugs in the treatment of non-small-cell lung cancer. | Br J Cancer | 2002 | https://conductscience.org/library/papers/12373594 | PubMed |
| 11027424 | Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer. | Br J Cancer | 2000 | https://conductscience.org/library/papers/11027424 | PubMed |
| 8624270 | A phase II study of cisplatin, vindesine and continuously infused 5-fluorouracil in the treatment of advanced non-small-cell lung cancer. Osaka Lung Cancer Chemotherapy Study Group. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8624270 | PubMed |
| 8262725 | Is there a role for vindesine in the treatment of non-small cell lung cancer? | Invest New Drugs | 1993 | https://conductscience.org/library/papers/8262725 | PubMed |
| 8130379 | Is the use of chemotherapy justified in non-small-cell lung cancer? | Drugs Aging | 1994 | https://conductscience.org/library/papers/8130379 | PubMed |
| 3801283 | Enhancement of cytotoxicity of vindesine and cis-platinum for human lung tumours by the use of verapamil in vitro. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3801283 | PubMed |
| 3022779 | Drug sensitivity of non small cell carcinoma of lung by clonogenic assay in several media. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3022779 | PubMed |
| 2157554 | A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2157554 | PubMed |
| 2108816 | The benefit of cisplatin-based polychemotherapy for adenocarcinoma of the lung. The Kyushu Lung Cancer Chemotherapy Study Group. | Cancer Chemother Pharmacol | 1990 | https://conductscience.org/library/papers/2108816 | PubMed |
| 1325579 | Lung cancer: a review of current therapeutic modalities. | Lung | 1992 | https://conductscience.org/library/papers/1325579 | PubMed |
| 1283850 | Current options in the treatment of non-small cell lung cancer. | Drugs | 1992 | https://conductscience.org/library/papers/1283850 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6540685
GET https://conductscience.org/api/papers/v1/6540685/authors